S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA)

Bibliographic Details
Main Authors:	M. S. Infante, J. Salmanton-García, A. Fernandez-Cruz, F. Marchesi, Z. RÁČIL, M. Hanakova, O. Jaksic, B. Weinbergerova, C. Besson, R. Duarte, F. Itri, T. VALKOVIĆ, A. Busca, A. Guidetti, A. GLENTHØJ, G. Collins, V. Bonuomo, U. Sili, G. Seval, M. Machado, A. Lopez-Garcia, R. Cordoba, O. Blennow, G. Abu-zeinah, S. Lemure, A. Kulasekararaj, I. Falces-Romero, C. Cattaneo, O. A. Cornely, J.-A. Hernandez-Rivas, L. Pagano
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844012.13018.0a

Internet